Document is current
Any future updates will be listed below
-
Authors
Bandyopadhyay, Abhishek
Williamson, Lauren E. https://orcid.org/0000-0002-2725-5826
Sirohi, Devika
Bailey, Kevin
Gilliland, Theron Jr.
Klose, Thomas https://orcid.org/0000-0002-2150-9792
Buda, Geeta
Trivette, Andrew
Sun, Chengqun
Julander, Justin G.
Klimstra, William B.
Crowe, James E. Jr. https://orcid.org/0000-0002-0049-1079
Kuhn, Richard J. https://orcid.org/0000-0003-4148-1026
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI095366-10)
- License Information
-
More Information
Article History
Received: 8 April 2024
Accepted: 24 May 2025
First Online: 19 August 2025
Competing interests
: L.E.W. has served as a consultant for BigHat Biosciences. J.E.C. has served as a consultant for Luna Labs USA, Merck Sharp & Dohme Corporation, Emergent Biosolutions, and BTG International Inc, is a former member of the Scientific Advisory Boards of Gigagen (Grifols) and Meissa Vaccines, and is founder of IDBiologics. The laboratory of J.E.C. received unrelated sponsored research agreements from AstraZeneca, Takeda Vaccines, and IDBiologics during the conduct of the study. Vanderbilt University has applied for a patent for the antibody studied in this paper. The remaining authors declare no competing interests.
